{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:05:06Z","timestamp":1704326706283},"reference-count":74,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p><jats:bold>Background.<\/jats:bold>The study was conducted to compare the efficacy and tolerability of two pantoprazole\u2010based triple therapies of different length in the eradication of<jats:italic>H. pylori.<\/jats:italic><\/jats:p><jats:p><jats:bold>Methods.<\/jats:bold>In this double\u2010blind, multicenter parallel group comparison,<jats:italic>H. pylori<\/jats:italic>\u2010positive patients were randomly assigned to either the PCM\u20107 group (7 days of pantoprazole 40 mg bid, clarithromycin 500 mg bid, metronidazole 500 mg bid) or the PCM\u201014 m group (modified 14 day therapy of the same regimen with metronidazole only given for 10 days due to labeling reasons).<jats:italic>H. pylori<\/jats:italic>status was determined by urease test, histology, culture, and<jats:sup>13<\/jats:sup>C\u2010urea breath test. Treatment outcome was assessed 6 weeks after intake of the last study medication.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold>The following eradication rates were achieved: for PCM\u20107 in the MITT population 83% (89\/107), in the PP population 84% (81\/97); for PCM\u201014 m in MITT 87% (92\/106), in PP 88% (91\/104). Ulcer healing rates were: for PCM\u20107 in MITT population 99% (106\/107), in the PP population 99% (96\/97); for PCM\u201014 m in MITT 99% (105\/106), in PP 99% (103\/104). Gastrointestinal symptoms and gastritis scores decreased in both treatment groups. Equivalence of treatment regimens could be proven for all populations. In total, 64 patients reported adverse events. Five serious adverse events occurred, all unrelated to the study medication.<\/jats:p><jats:p><jats:bold>Conclusion.<\/jats:bold>The two pantoprazole\u2010based triple therapies tested in this study are equally effective in<jats:italic>H. pylori<\/jats:italic>eradication, ulcer healing and relief from ulcer pain. It is concluded that 7 days of triple therapy are generally sufficient.<\/jats:p>","DOI":"10.1046\/j.1523-5378.2000.00006.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:21:53Z","timestamp":1047424913000},"page":"41-51","source":"Crossref","is-referenced-by-count":33,"title":["Eradication of<i>H. pylori<\/i>with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head\u2010to\u2010Head Comparison Between Two Regimens of Different Duration"],"prefix":"10.1111","volume":"5","author":[{"given":"Hans\u2010Gerd","family":"Dammann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich R.","family":"F\u00f6lsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckhart G.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef\u2010Hasso","family":"Von Kleist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans\u2010Ulrich","family":"Kl\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Kist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5694\/j.1326-5377.1985.tb113444.x","article-title":"Pyloric Campylobacter infection and gastrointestinal disease.","volume":"142","author":"Marshall BJ","year":"1985","journal-title":"Med J Aust"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","unstructured":"Talley NJ. IsHelicobacter pyloria cause of non\u2010ulcer dyspepsia?. In: Malfertheiner P Ditschuneit H eds.Helicobacter pylori Gastritis and Peptic Ulcer.Berlin: Springer Verlag 1990.","DOI":"10.1007\/978-3-642-75315-2_53"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1987.tb00637.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00541.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7126.162"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-9-705"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.4.466"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005771"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094856"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094518"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archinte.1997.00440220091012","article-title":"Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.","volume":"157","author":"Taylor JL","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90511-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)23652-X"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.18.1958"},{"key":"e_1_2_6_19_2","first-page":"239","article-title":"Cost\u2010effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.","volume":"91","author":"Vakil N","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00004"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference.Helicobacter pyloriin peptic ulcer disease. JAMA 1994;272:65\u20139.","DOI":"10.1001\/jama.272.1.65"},{"key":"e_1_2_6_22_2","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection.","volume":"41","author":"European Helicobacter Pylori Study Group","year":"1997","journal-title":"The Maastricht Consensus Report. Gut"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199409000-00004"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00349.x"},{"key":"e_1_2_6_25_2","first-page":"835","article-title":"Efficacy and optimum dose of omeprazole in a new 1\u2010week triple therapy regime to eradicate Helicobacter pylori.","volume":"7","author":"Moayyedi P","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_26_2","first-page":"9","article-title":"One\u2010week low\u2010dose therapy for the eradication of Helicobacter pylori infection.","volume":"7","author":"Labenz J","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_27_2","first-page":"943","article-title":"Low dose, short\u2010term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.","volume":"90","author":"Jaup BH","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_29_2","first-page":"735","article-title":"One\u2010week triple therapy for Helicobacter pylori: a multicenter comparative study.","volume":"41","author":"Misiewicz JJ","year":"1997","journal-title":"Lansoprazole Helicobacter Study Group Gut"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.130301000.x"},{"key":"e_1_2_6_31_2","first-page":"122","article-title":"Short\u2010term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori.","volume":"25","author":"Labenz J","year":"1995","journal-title":"Leber Magen Darm"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00343.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.111282000.x"},{"key":"e_1_2_6_34_2","first-page":"407","article-title":"Das Sydney System. Eine neue weltweite Gastritis\u2010Klassifikation.","volume":"109","author":"Stolte M","year":"1991","journal-title":"Fortschr Med"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01467.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.2.185"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00088.x"},{"key":"e_1_2_6_38_2","first-page":"85","article-title":"An effective one\u2010week Helicobacter pylori eradication therapy using omeprazole, clarithromycin and metronidazole.","volume":"6","author":"Powell KU","year":"1995","journal-title":"Br J Clin Res"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00374.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501193320302"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.43"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00319.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109003956"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90606-3"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb101251.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409105357"},{"key":"e_1_2_6_48_2","first-page":"281","article-title":"Changes in the gastric mucosa following eradication of Helicobacter pylori.","volume":"6","author":"Genta RM","year":"1993","journal-title":"Mod Pathol"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199309000-00006"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199305000-00005"},{"key":"e_1_2_6_51_2","first-page":"A226","article-title":"Frequent metronidazole resistance without significant impact on the high cure rate of Helicobacter pylori (HP) infection by triple therapy with omeprazole (OME), metronidazole (MET), and clarithromycin (CLA) (Abstract).","volume":"110","author":"Peitz U","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_6_52_2","first-page":"A48","article-title":"Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin (Abstract).","volume":"110","author":"Adamek RJ","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"e_1_2_6_53_2","first-page":"A55","article-title":"Effects of antibiotic\u2010resistance on clarithromycin\u2010combined triple therapy for Helicobacter pylori (Abstract).","volume":"37","author":"Xia HX","year":"1995","journal-title":"Gut"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199711000-00012"},{"key":"e_1_2_6_55_2","unstructured":"M\u00e9graud F.H. pyloriresistance to antibiotics. In: Hunt RH Tytgat GNJ eds.Helicobacter pylori\u2014Basic Mechanism to Clinical Cure. Dordrecht: Kluwer Academic Publishers 1994: 570\u201383."},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199303000-00004"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199407000-00004"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.1.163"},{"key":"e_1_2_6_59_2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.1992.tb00556.x","article-title":"Experience with \u2018triple\u2019 anti\u2010Helicobacter pylori eradication therapy: side\u2010effects and the importance of testing the pre\u2010treatment bacterial isolate for metronidazole resistance.","volume":"4","author":"Bell GD","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_6_60_2","first-page":"817","article-title":"Evaluation of various multi\u2010drug eradication regimens for Helicobacter pylori.","volume":"4","author":"Burette A","year":"1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.005_c.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00085.x"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.100272000.x"},{"issue":"2","key":"e_1_2_6_64_2","first-page":"A6","article-title":"Relevance of metronidazole resistance in predicting failure of omeprazole, clarithro mycin and tinidazole to eradicate Helicobacter pylori (Abstract).","volume":"39","author":"Moayyedi P","year":"1996","journal-title":"Gut"},{"issue":"2","key":"e_1_2_6_65_2","first-page":"A34","article-title":"Comparison of the efficacy of two short\u2010term triple therapies based on clarithromycin in the eradication of Helicobacter pylori (HP): a randomised study (Abstract).","volume":"39","author":"Georgopoulos S","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.39310.x"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.675"},{"issue":"2","key":"e_1_2_6_68_2","first-page":"A35","article-title":"Randomised study comparing two seven days triple therapies with lansoprazole and low dose of clarithromycin plus amoxicillin or tinidazole for H. pylori eradication (Abstract).","volume":"39","author":"Lamouliatte H","year":"1996","journal-title":"Gut"},{"issue":"4","key":"e_1_2_6_69_2","first-page":"A40","article-title":"Efficacy and tolerability of a short term, low\u2010dose triple therapy for eradication of Helicobacter pylori (Abstract).","volume":"104","author":"Bazzoli F","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92111-E"},{"key":"e_1_2_6_71_2","first-page":"248","article-title":"Highly effective twice\u2010daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?","volume":"92","author":"Lerang F","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.3.473"},{"issue":"2","key":"e_1_2_6_73_2","first-page":"A12","article-title":"Association of clarithromycin sensitivity test results with eradication of Helicobacter pylori (Abstract).","volume":"39","author":"Tompkins D","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.4.639"},{"key":"e_1_2_6_75_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018882804607"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1523-5378.2000.00006.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2000.00006.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1523-5378.2000.00006.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2000.00006.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:54:30Z","timestamp":1704311670000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1523-5378.2000.00006.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1046\/j.1523-5378.2000.00006.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-5378.2000.00006.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}